Contribution of defective von Willebrand factor (VWF) multimerization, regulated storage, and secretion to type 1C von Willebrand disease (VWD)

被引：0
作者：
Jakab, D. A. [1 ]
Jacobi, P. M. [1 ]
Haberichter, S. L. [1 ,2 ]
机构：
[1] BloodCtr Wisconsin, Milwaukee, WI USA
[2] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2014年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
VWF12
引用
收藏
页码：94 / 94
页数：1
相关论文
共 50 条
  • [21] PLATELET VON-WILLEBRAND-FACTOR (VWF) AND VON-WILLEBRANDS DISEASE (VWD) TYPE-B
    THOMAS, K
    FIRKIN, B
    TUNE, E
    STREET, A
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 952 - 952
  • [22] Homozygous and heterozygous expression of type 2a von willebrand disease (VWD) variants: negative impact on mechanisms critical for von willebrand factor (VWF) processing and secretion
    Jacobi, P. M.
    Gill, J. C.
    Friedman, K. D.
    Montgomery, R. R.
    Haberichter, S. L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 68 - 69
  • [23] Expression studies of von Willebrand factor missense mutations causing type 1 or type 2 von Willebrand disease (VWD)
    Yadegari, H.
    Driesen, J.
    Hambitzer, P.
    Pavlova, A.
    Oldenburg, J.
    HAEMOPHILIA, 2012, 18 : 195 - 196
  • [24] Pharmacokinetic analysis of a von Willebrand factor/factor VIII (VWF/FVIII) concentrate in adults-and children with von Willebrand disease (VWD)
    Di Paola, Jorge
    Lethagen, Stephan
    Gill, Joan
    Mannucci, Pier
    Bemstein, Jonathan
    Nichols, William
    Friedman, Carl
    Knaub, Sigurd
    Bergman, Garrett
    BLOOD, 2007, 110 (11) : 637A - 637A
  • [25] Analysis of intracellular storage and regulated secretion of 3 von Willebrand disease-causing variants of von Willebrand factor
    Michaux, G
    Hewlett, LJ
    Messenger, SL
    Goodeve, AC
    Peake, IR
    Daly, ME
    Cutler, DF
    BLOOD, 2003, 102 (07) : 2452 - 2458
  • [26] Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor
    Allen, S
    Abuzenadah, AM
    Blagg, JL
    Hinks, J
    Nesbitt, IM
    Goodeve, AC
    Gursel, T
    Ingerslev, J
    Peake, IR
    Daly, ME
    BLOOD, 2000, 95 (06) : 2000 - 2007
  • [27] The contribution of a reduced von Willebrand factor survival in type 2 von Willebrand disease
    Gallinaro, L.
    Cattini, M. G.
    Pontara, E.
    Sartorello, F.
    Daidone, V
    Padrini, R.
    Bertomoro, A.
    Pagnan, A.
    Casonato, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 843 - 843
  • [28] A novel von Willebrand disease-causing mutation (Arg273Trp) in the von Willebrand factor propeptide that results in defective multimerization and secretion
    Allen, S
    Abuzenadah, AM
    Hinks, J
    Blagg, JL
    Gursel, T
    Ingerslev, J
    Goodeve, AC
    Peake, IR
    Daly, ME
    BLOOD, 2000, 96 (02) : 560 - 568
  • [29] Von Willebrand Factor (VWF) Propeptide and Factor VIII (FVIII) Levels Identify the Contribution of Decreased Synthesis and/or Increased Clearance Mechanisms in the Pathogenesis of Type 1 Von Willebrand Disease (VWD) in the Zimmerman Program
    Haberichter, Sandra L.
    Christopherson, Pamela A.
    Flood, Veronica H.
    Gill, Joan Cox
    Friedman, Kenneth D.
    Montgomery, Robert R.
    BLOOD, 2016, 128 (22)
  • [30] Phenotype assignment of Type 2 von Willebrand disease (VWD) variants by a single ELISA-based assay of von Willebrand factor (VWF) functions
    Roberts, J. C.
    Morateck, P. A.
    Christopherson, P. A.
    Yan, K.
    Hoffmann, R. G.
    Gill, J. C.
    Montgomery, R. R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 90 - 91
12345